Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:4:283-301.
doi: 10.2147/CLEP.S34285. Epub 2012 Nov 7.

Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors

Gena P Kanas  1 , Aliki Taylor, John N Primrose, Wendy J Langeberg, Michael A Kelsh, Fionna S Mowat, Dominik D Alexander, Michael A Choti, Graeme Poston
Affiliations

Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors

Gena P Kanas et al. Clin Epidemiol. 2012.

Abstract

Background: Hepatic metastases develop in approximately 50% of colorectal cancer (CRC) cases. We performed a review and meta-analysis to evaluate survival after resection of CRC liver metastases (CLMs) and estimated the summary effect for seven prognostic factors.

Methods: Studies published between 1999 and 2010, indexed on Medline, that reported survival after resection of CLMs, were reviewed. Meta-relative risks for survival by prognostic factor were calculated, stratified by study size and annual clinic volume. Cumulative meta-analysis results by annual clinic volume were plotted.

Results: Five- and 10-year survival ranged from 16% to 74% (median 38%) and 9% to 69% (median 26%), respectively, based on 60 studies. The overall summary median survival time was 3.6 (range: 1.7-7.3) years. Meta-relative risks (95% confidence intervals) by prognostic factor were: node positive primary, 1.6 (1.5-1.7); carcinoembryonic antigen level, 1.9 (1.1-3.2); extrahepatic disease, 1.9 (1.5-2.4); poor tumor grade, 1.9 (1.3-2.7); positive margin, 2.0 (1.7-2.5); >1 liver metastases, 1.6 (1.4-1.8); and >3 cm tumor diameter, 1.5 (1.3-1.8). Cumulative meta-analyses by annual clinic volume suggested improved survival with increasing volume.

Conclusion: The overall median survival following CLM liver resection was 3.6 years. All seven investigated prognostic factors showed a modest but significant predictive relationship with survival, and certain prognostic factors may prove useful in determining optimal therapeutic options. Due to the increasing complexity of surgical interventions for CLM and the inclusion of patients with higher disease burdens, future studies should consider the potential for selection and referral bias on survival.

Keywords: liver resection; meta-analysis; metastatic colorectal cancer; survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A diagram illustrating the study selection and exclusion process.
Figure 2
Figure 2
Meta-analysis forest plots of the relative risk and 95% confidence intervals of survival after liver resection in metastatic colorectal cancer reported in the literature for each of the seven identified prognostic factors. Abbreviation: CEA, carcinoembryonic antigen.
Figure 3
Figure 3
Summary of median survival after liver resection for metastatic colorectal cancer reported or estimated from the studies included. Note: Results are shown by date of publication as well as the seven identified prognostic factors. Abbreviations: CEA, carcinoembryonic antigen; CI, confidence interval.
Figure 3
Figure 3
Summary of median survival after liver resection for metastatic colorectal cancer reported or estimated from the studies included. Note: Results are shown by date of publication as well as the seven identified prognostic factors. Abbreviations: CEA, carcinoembryonic antigen; CI, confidence interval.
Figure 4
Figure 4
Cumulative meta-analysis of meta relative risks by patient volume and seven prognostic factors identified. Abbreviations: CEA, carcinoembryonic antigen; CI, confidence interval.
Figure 4
Figure 4
Cumulative meta-analysis of meta relative risks by patient volume and seven prognostic factors identified. Abbreviations: CEA, carcinoembryonic antigen; CI, confidence interval.
See this image and copyright information in PMC

References

    1. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13(10):1271–1280. - PubMed
    1. Donadon M, Ribero D, Morris-Stiff G, Abdalla EK, Vauthey JN. New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res. 2007;1(1):20–27. - PMC - PubMed
    1. Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006;141(5):460–466. discussion 466–467. - PubMed
    1. Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247(1):125–135. - PubMed
    1. Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol. 2005;16(8):1311–1319. - PubMed